Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.3 USD 0.41% Market Closed
Market Cap: 786.7m USD
Have any thoughts about
Avid Bioservices Inc?
Write Note

Avid Bioservices Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Avid Bioservices Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Other Long-Term Assets
$4.7m
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$8.3B
CAGR 3-Years
20%
CAGR 5-Years
44%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$7.2B
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
23%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$10.4B
CAGR 3-Years
18%
CAGR 5-Years
43%
CAGR 10-Years
21%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$3.2B
CAGR 3-Years
49%
CAGR 5-Years
17%
CAGR 10-Years
95%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$4.1B
CAGR 3-Years
70%
CAGR 5-Years
34%
CAGR 10-Years
31%
No Stocks Found

Avid Bioservices Inc
Glance View

Market Cap
784.6m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
18.42 USD
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Avid Bioservices Inc's Other Long-Term Assets?
Other Long-Term Assets
4.7m USD

Based on the financial report for Jul 31, 2024, Avid Bioservices Inc's Other Long-Term Assets amounts to 4.7m USD.

What is Avid Bioservices Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
7%

Over the last year, the Other Long-Term Assets growth was -96%. The average annual Other Long-Term Assets growth rates for Avid Bioservices Inc have been 27% over the past three years , 25% over the past five years , and 7% over the past ten years .

Back to Top